Epigenomics AG Share Price Deutsche Boerse AG
Stocks
ECX
DE000A11QW50
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.785 EUR | -1.92% |
|
+9.51% | -4.03% |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 22/07/25 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 824K 937K 766K 704K 1.32M 90.77M 1.34M 9.16M 3.57M 44.27M 3.52M 3.44M 154M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.79M 13.41M 10.95M 10.07M 18.89M 1.3B 19.23M 131M 51.09M 633M 50.33M 49.24M 2.2B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 31/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 28/02/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 31/05/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 04/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.92% | +9.51% | - | - | 941K | |
| -0.22% | -2.26% | +139.07% | +102.52% | 4.63B | |
| +1.64% | +0.95% | +105.24% | +176.11% | 3.51B | |
| -0.77% | +10.09% | +29.22% | -33.12% | 2.31B | |
| -1.76% | -3.16% | -28.19% | -36.48% | 2.13B | |
| -0.45% | -6.77% | +186.66% | +253.81% | 1.95B | |
| -0.70% | -0.56% | +169.08% | -43.60% | 1.05B | |
| +2.42% | -3.50% | -8.01% | +28.14% | 830M | |
| +0.67% | -7.13% | -38.55% | -13.58% | 494M | |
| +6.72% | -9.36% | -4.60% | - | 407M | |
| Average | +0.56% | -1.18% | +61.10% | +54.23% | 1.92B | |
| Weighted average by Cap. | +0.16% | +0.05% | +88.69% | +83.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.29K 22.3K 20.51K 38.46K 2.64M 39.14K 267K 104K 1.29M 102K 100K 4.47M |
| Net income | -3.35M -3.81M -3.11M -2.86M -5.37M -369M -5.47M -37.24M -14.52M -180M -14.31M -14M -625M | -314K -357K -292K -268K -503K -34.57M -512K -3.49M -1.36M -16.86M -1.34M -1.31M -58.51M |
| Net Debt | 10.46M 11.89M 9.71M 8.93M 16.75M 1.15B 17.05M 116M 45.3M 562M 44.63M 43.66M 1.95B | 10.97M 12.47M 10.19M 9.37M 17.57M 1.21B 17.89M 122M 47.52M 589M 46.81M 45.8M 2.04B |
Employees
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ECX Stock
- ECX Stock
Select your edition
All financial news and data tailored to specific country editions
